Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Immunotherapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Melanoma 4 Esophageal Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Rectal Neoplasms 2 Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Muscle-invasive Bladder Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Limited Stage Small Cell Lung Cancer 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Nivolumab 8 pembrolizumab 7 avelumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡